UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies

Annals of oncology, 2008-07, Vol.19 (7), p.1327-1330

2008

Volltextzugriff (PDF)

On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia

Leukemia, 2008-09, Vol.22 (9), p.1707-1711

2008

Volltextzugriff (PDF)

Phase 1 study of PTK787 ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome

Leukemia, 2006-06, Vol.20 (6), p.952-957

2006

Volltextzugriff (PDF)

Management of Refractory Acute Myeloid Leukemia: Re-induction Therapy or Straight to Transplantation?

Current hematologic malignancy reports, 2012-03, Vol.7 (1), p.74-77

2012

Volltextzugriff (PDF)

A case of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis (POIKTMP) with the emphasis on cutaneous histopathological findings

Journal of the European Academy of Dermatology and Venereology, 2018-12, Vol.32 (12), p.e443-e445

2018

Volltextzugriff (PDF)

Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia

Journal of thrombosis and haemostasis, 2011-11, Vol.9 (11), p.2302-2310

2011

Volltextzugriff (PDF)

Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia

Leukemia research, 2012-10, Vol.36 (10), p.1283-1289

2012

Volltextzugriff (PDF)

Activation of FGFR1β signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cells

Leukemia, 2006-06, Vol.20 (6), p.979-986

2006

Volltextzugriff (PDF)

Phase I clinical and laboratory evaluation of topotecan and cytarabine in patients with acute leukemia

Journal of clinical oncology, 1997-01, Vol.15 (1), p.44-51

1997

Volltextzugriff (PDF)

Phase III Randomized Multicenter Study of a Humanized Anti-CD33 Monoclonal Antibody, Lintuzumab, in Combination With Chemotherapy, Versus Chemotherapy Alone in Patients With Refractory or First-Relapsed Acute Myeloid Leukemia

Journal of clinical oncology, 2005-06, Vol.23 (18), p.4110-4116

2005

Volltextzugriff (PDF)

Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy

Leukemia, 2001-06, Vol.15 (6), p.963-970

2001

Volltextzugriff (PDF)

Cell cycle specificity of apoptosis during treatment of leukaemias

Apoptosis (London), 1997, Vol.2 (1), p.25-39

1997

Volltextzugriff (PDF)

Efficacy and Safety of Gemtuzumab Ozogamicin in Patients with Poor-prognosis Acute Myeloid Leukemia

Leukemia & lymphoma, 2002-10, Vol.43 (10), p.1951-1955

2002

Volltextzugriff (PDF)

Homoharringtonine in patients with myelodysplastic syndrome (MDS) and MDS evolving to acute myeloid leukemia

Leukemia, 1996-01, Vol.10 (1), p.40

1996

Volltextzugriff (PDF)

High-dose cytarabine-based therapy in adults with acute lymphoblastic leukemia

Leukemia research, 2000-03, Vol.24 (3), p.189

Feldman, E J

2000

Volltextzugriff (PDF)

A randomized trial of high- vs standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemia

Leukemia, 1997-04, Vol.11 (4), p.485-489

1997

Volltextzugriff (PDF)

Phase I clinical and pharmacokinetic evaluation of high-dose mitoxantrone in combination with cytarabine in patients with acute leukemia

Journal of clinical oncology, 1993-10, Vol.11 (10), p.2002-2009

1993

Volltextzugriff (PDF)

Clinical and laboratory evaluation of all‐trans retinoic acid modulation of chemotherapy in patients with acute myelogenous leukaemia

British journal of haematology, 2000-01, Vol.108 (1), p.40-47

2000

Volltextzugriff (PDF)

A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia

Journal of clinical oncology, 1991-09, Vol.9 (9), p.1562-1569

1991

Volltextzugriff (PDF)

Farnesyltransferase inhibitors in myelodysplastic syndrome

Current hematology reports, 2005-05, Vol.4 (3), p.186

Feldman, E J

2005

Volltextzugriff (PDF)

The recognition and investigation of X-linked learning disability syndromes

Journal of intellectual disability research, 1996-10, Vol.40 (5), p.400-411

FELDMAN, E. J

1996

Volltextzugriff (PDF)

Single and double autotransplants for relapsing/refractory Hodgkin's disease : results of two consecutive trials

Bone marrow transplantation (Basingstoke), 1997-03, Vol.19 (5), p.449-454

1997

Volltextzugriff (PDF)

Evaluation of in vivo induction of apoptosis in patients with acute leukemia treated on a phase I study of Paclitaxel

Leukemia, 1995-11, Vol.9 (11), p.1961-1966

1995

Volltextzugriff (PDF)

Farnesyltransferase inhibitors in myelodysplastic syndrome

Current hematologic malignancy reports, 2006-03, Vol.1 (1), p.20-24

Feldman, E J

2006

Volltextzugriff (PDF)

A Phase I–II trial of escalating doses of mitoxantrone with fixed doses of cytarabine plus fludarabine as salvage therapy for patients with acute leukemia and the blastic phase of chronic myelogenous leukemia

Cancer, 1999-12, Vol.86 (11), p.2246-2251

1999

Volltextzugriff (PDF)

1 – 25 von 5.522

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.803)
Mit Volltextzugriff
(4.370)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.344)
Life Sciences & Biomedicine
(2.501)
Humans
(2.212)
Male
(1.378)
Female
(1.303)
Biological And Medical Sciences
(1.011)
Middle Aged
(870)
Medical Sciences
(854)
Adult
(792)
Physical Sciences
(687)
Aged
(633)
Animals
(568)
Physics
(493)
Adolescent
(341)
Child
(320)
General & Internal Medicine
(258)
Treatment Outcome
(257)
Exact Sciences And Technology
(253)
Cardiovascular System & Cardiology
(250)
Oncology
(240)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(2.712)
Free E-Journal (出版社公開部分のみ）
(2.558)
Journals@Ovid Full Text
(2.079)
NUS Single-Journal Subscriptions
(1.958)
Ingenta
(1.917)
Elsevier ScienceDirect Journals Complete
(1.043)
Wiley Online Library
(705)
IngentaConnect Journals
(649)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(613)
Wiley Online Library Full Collection 2018
(520)
American Physical Society
(373)
American Physical Society - Physical Review Online Archive (PROLA)
(339)
Springer Online Journals Complete
(294)
Oxford Journals
(273)
JSTOR
(229)
Oxford Journals 2020 Medicine
(219)
Nature_系列刊
(191)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(159)
Taylor & Francis
(129)
Taylor & Francis:Master (3349 titles)
(127)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies

On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia

Phase 1 study of PTK787 ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome

Management of Refractory Acute Myeloid Leukemia: Re-induction Therapy or Straight to Transplantation?

A case of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis (POIKTMP) with the emphasis on cutaneous histopathological findings

Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia

Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia

Activation of FGFR1β signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cells

Phase I clinical and laboratory evaluation of topotecan and cytarabine in patients with acute leukemia

Phase III Randomized Multicenter Study of a Humanized Anti-CD33 Monoclonal Antibody, Lintuzumab, in Combination With Chemotherapy, Versus Chemotherapy Alone in Patients With Refractory or First-Relapsed Acute Myeloid Leukemia

Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy

Cell cycle specificity of apoptosis during treatment of leukaemias

Efficacy and Safety of Gemtuzumab Ozogamicin in Patients with Poor-prognosis Acute Myeloid Leukemia

Homoharringtonine in patients with myelodysplastic syndrome (MDS) and MDS evolving to acute myeloid leukemia

High-dose cytarabine-based therapy in adults with acute lymphoblastic leukemia

A randomized trial of high- vs standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemia

Phase I clinical and pharmacokinetic evaluation of high-dose mitoxantrone in combination with cytarabine in patients with acute leukemia

Clinical and laboratory evaluation of all‐trans retinoic acid modulation of chemotherapy in patients with acute myelogenous leukaemia

A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia

Farnesyltransferase inhibitors in myelodysplastic syndrome

The recognition and investigation of X-linked learning disability syndromes

Single and double autotransplants for relapsing/refractory Hodgkin's disease : results of two consecutive trials

Evaluation of in vivo induction of apoptosis in patients with acute leukemia treated on a phase I study of Paclitaxel

Farnesyltransferase inhibitors in myelodysplastic syndrome

A Phase I–II trial of escalating doses of mitoxantrone with fixed doses of cytarabine plus fludarabine as salvage therapy for patients with acute leukemia and the blastic phase of chronic myelogenous leukemia

Suchergebnisse filtern